Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions

NCT03553875 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped requested by the IRB

Conditions

Autism
Autism Spectrum Disorder
Nonverbal Learning Disability

Interventions

DRUG: Memantine Hydrochloride
DRUG: Placebo

Sponsor

Massachusetts General Hospital